MS-DRG 949

Principal Diagnosis - Pdx

• T43.636S Underdosing of methylphenidate, sequela
• T43.641D Poisoning by ecstasy, accidental (unintentional), subsequent encounter
• T43.642D Poisoning by ecstasy, intentional self-harm, subsequent encounter
• T43.643D Poisoning by ecstasy, assault, subsequent encounter
• T43.644D Poisoning by ecstasy, undetermined, subsequent encounter
• T43.651D Poisoning by methamphetamines accidental (unintentional), subsequent encounter
• T43.652D Poisoning by methamphetamines intentional self-harm, subsequent encounter
• T43.653D Poisoning by methamphetamines, assault, subsequent encounter
• T43.654D Poisoning by methamphetamines, undetermined, subsequent encounter
• T43.655D Adverse effect of methamphetamines, subsequent encounter
• T43.656D Underdosing of methamphetamines, subsequent encounter
• T43.656S Underdosing of methamphetamines, sequela
• T43.691D Poisoning by other psychostimulants, accidental (unintentional), subsequent encounter
• T43.692D Poisoning by other psychostimulants, intentional self-harm, subsequent encounter
• T43.693D Poisoning by other psychostimulants, assault, subsequent encounter
• T43.694D Poisoning by other psychostimulants, undetermined, subsequent encounter
• T43.695D Adverse effect of other psychostimulants, subsequent encounter
• T43.696D Underdosing of other psychostimulants, subsequent encounter
• T43.696S Underdosing of other psychostimulants, sequela
• T43.8X1D Poisoning by other psychotropic drugs, accidental (unintentional), subsequent encounter
• T43.8X2D Poisoning by other psychotropic drugs, intentional self-harm, subsequent encounter
• T43.8X3D Poisoning by other psychotropic drugs, assault, subsequent encounter
• T43.8X4D Poisoning by other psychotropic drugs, undetermined, subsequent encounter
• T43.8X5D Adverse effect of other psychotropic drugs, subsequent encounter
• T43.8X6D Underdosing of other psychotropic drugs, subsequent encounter
• T43.8X6S Underdosing of other psychotropic drugs, sequela
• T43.91XD Poisoning by unspecified psychotropic drug, accidental (unintentional), subsequent encounter
• T43.92XD Poisoning by unspecified psychotropic drug, intentional self-harm, subsequent encounter
• T43.93XD Poisoning by unspecified psychotropic drug, assault, subsequent encounter
• T43.94XD Poisoning by unspecified psychotropic drug, undetermined, subsequent encounter
• T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter
• T43.96XD Underdosing of unspecified psychotropic drug, subsequent encounter
• T43.96XS Underdosing of unspecified psychotropic drug, sequela
• T44.0X1D Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter
• T44.0X2D Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter
• T44.0X3D Poisoning by anticholinesterase agents, assault, subsequent encounter
• T44.0X4D Poisoning by anticholinesterase agents, undetermined, subsequent encounter
• T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter
• T44.0X6D Underdosing of anticholinesterase agents, subsequent encounter
• T44.0X6S Underdosing of anticholinesterase agents, sequela
• T44.1X1D Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter
• T44.1X2D Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter
• T44.1X3D Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter
• T44.1X4D Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter
• T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
• T44.1X6D Underdosing of other parasympathomimetics [cholinergics], subsequent encounter
• T44.1X6S Underdosing of other parasympathomimetics [cholinergics], sequela
• T44.2X1D Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter
• T44.2X2D Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter
• T44.2X3D Poisoning by ganglionic blocking drugs, assault, subsequent encounter
• T44.2X4D Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter
• T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter
• T44.2X6D Underdosing of ganglionic blocking drugs, subsequent encounter
• T44.2X6S Underdosing of ganglionic blocking drugs, sequela
• T44.3X1D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter
• T44.3X2D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter
• T44.3X3D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter
• T44.3X4D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter
• T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
• T44.3X6D Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
• T44.3X6S Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
• T44.4X1D Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
• T44.4X2D Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter
• T44.4X3D Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter
• T44.4X4D Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter
• T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
• T44.4X6D Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter
• T44.4X6S Underdosing of predominantly alpha-adrenoreceptor agonists, sequela
• T44.5X1D Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
• T44.5X2D Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter
• T44.5X3D Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter
• T44.5X4D Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter
• T44.5X5D Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
• T44.5X6D Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter
• T44.5X6S Underdosing of predominantly beta-adrenoreceptor agonists, sequela
• T44.6X1D Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
• T44.6X2D Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
• T44.6X3D Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter
• T44.6X4D Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter
• T44.6X5D Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
• T44.6X6D Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter
• T44.6X6S Underdosing of alpha-adrenoreceptor antagonists, sequela
• T44.7X1D Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
• T44.7X2D Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
• T44.7X3D Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter
• T44.7X4D Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter
• T44.7X5D Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
• T44.7X6D Underdosing of beta-adrenoreceptor antagonists, subsequent encounter
• T44.7X6S Underdosing of beta-adrenoreceptor antagonists, sequela
• T44.8X1D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter
• T44.8X2D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter
• T44.8X3D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter
• T44.8X4D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter
• T44.8X5D Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
• T44.8X6D Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
• T44.8X6S Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela
• T44.901D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter
• T44.902D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter
• T44.903D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter
• T44.904D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter